Englander Institute for Precision Medicine

Publications

Found 19 results
Author Title Type [ Year(Asc)]
Filters: Author is Formenti, Silvia C  [Clear All Filters]
2024
Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P et al..  2024.  Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.. Nat Commun. 15(1):225.
Charpentier M, Bloy N, Formenti SC, Galluzzi L, Demaria S.  2024.  Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.. J Vis Exp. (206)
2023
Klapp V, Buqué A, Bloy N, Sato A, Yamazaki T, Zhou XKathy, Formenti SC, Galluzzi L, Petroni G.  2023.  Cellular senescence in the response of HR breast cancer to radiotherapy and CDK4/6 inhibitors.. J Transl Med. 21(1):110.
Galluzzi L, Aryankalayil MJ, C Coleman N, Formenti SC.  2023.  Emerging evidence for adapting radiotherapy to immunotherapy.. Nat Rev Clin Oncol.
Galassi C, Klapp V, Formenti SC, Demaria S, Galluzzi L.  2023.  Immunologically relevant effects of radiation therapy on the tumor microenvironment.. Essays Biochem.
Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P et al..  2023.  Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.. Nat Commun. 14(1):8435.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche J-B, Golden E, Boyer O, Van Besien K, Formenti SC, Galluzzi L et al..  2023.  Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.. Cell Death Dis. 14(5):305.
Marciscano AE, Wolfe S, Zhou XKathy, Barbieri CE, Formenti SC, Hu JC, Molina AM, Nanus DM, Nauseef JT, Scherr DS et al..  2023.  Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).. BMC Cancer. 23(1):781.
Gregucci F, Spada S, Barcellos-Hoff MHelen, Bhardwaj N, Hak CChan Wah, Fiorentino A, Guha C, Guzman ML, Harrington K, Herrera FG et al..  2023.  Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.. Oncoimmunology. 12(1):2222560.
2022
Petroni G, Cantley LC, Santambrogio L, Formenti SC, Galluzzi L.  2022.  Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.. Nat Rev Clin Oncol. 19(2):114-131.
2021
Petroni G, Buqué A, Yamazaki T, Bloy N, Di Liberto M, Chen-Kiang S, Formenti SC, Galluzzi L.  2021.  Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER Breast Cancer.. Clin Cancer Res. 27(7):1855-1863.
Lhuillier C, Rudqvist N-P, Yamazaki T, Zhang T, Charpentier M, Galluzzi L, Dephoure N, Clement CC, Santambrogio L, Zhou XKathy et al..  2021.  Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.. J Clin Invest. 131(5)
2020
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez ABuqué, Chan TA, Coukos G, Demaria S, Deutsch E et al..  2020.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.. J Immunother Cancer. 8(1)
Pilones KA, Hensler M, Daviaud C, Kraynak J, Fucikova J, Galluzzi L, Demaria S, Formenti SC.  2020.  Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.. Oncoimmunology. 9(1):1830524.
Petroni G, Formenti SC, Chen-Kiang S, Galluzzi L.  2020.  Immunomodulation by anticancer cell cycle inhibitors.. Nat Rev Immunol. 20(11):669-679.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A et al..  2020.  Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.. Nat Commun. 11(1):3819.
Yamazaki T, Kirchmair A, Sato A, Buqué A, Rybstein M, Petroni G, Bloy N, Finotello F, Stafford L, Manzano ENavarro et al..  2020.  Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.. Nat Immunol. 21(10):1160-1171.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A et al..  2020.  Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.. Nat Commun. 11(1):4787.
2019
Lhuillier C, Rudqvist N-P, Elemento O, Formenti SC, Demaria S.  2019.  Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system.. Genome Med. 11(1):40.